title: Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1.
abstract: BACKGROUND
  The growth hormone (GH)/insulin-like growth factor (IGF) system is thought to participate in the glomerulosclerosis process. Because IGF-binding proteins (IGFBPs) modulate IGF actions and hence GH secretion, this study assessed whether mice transgenic for human IGFBP-1 have altered susceptibility to glomerulosclerosis.
  
  
  METHODS
  A line of transgenic mice that express human IGFBP-1 mRNA in the liver under the control of the alpha1-antitrypsin promoter has been obtained, and morphological changes in the kidney tissue were assessed. Glomerulosclerosis was identified using light microscopy, light microscopic morphometry, and electron microscopy. Extracellular matrix components were analyzed by immunohistochemistry.
  
  
  RESULTS
  There was a marked increase in mesangial extracellular matrix area in homozygous transgenic mice at three months of age as compared with heterozygous transgenic mice and nontransgenic littermates. These changes were not associated with alterations in glomerular volume or cellularity. The expansion of extracellular matrix area was related to a marked increase in laminin and type IV collagen and to the appearance of type I collagen.
  
  
  CONCLUSIONS
  These observations indicate that the enhanced expression of IGFBP-1 may result in the development of glomerulosclerosis without glomerular hypertrophy. The changes are potentially related to a decrease in IGF-I availability and/or to an IGF-I-independent role of IGFBP-1.
authors.affiliation: INSERM U489, Hôpital Tenon, INSERM U515, Hôpital Saint-Antoine, and Service d'Anatomie Pathologique, Hôpital Tenon, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Doublier
authors.forename: D
authors.initials: D
authors.lastname: Seurin
authors.forename: B
authors.initials: B
authors.lastname: Fouqueray
authors.forename: M C
authors.initials: MC
authors.lastname: Verpont
authors.forename: P
authors.initials: P
authors.lastname: Callard
authors.forename: L J
authors.initials: LJ
authors.lastname: Striker
authors.forename: G E
authors.initials: GE
authors.lastname: Striker
authors.forename: M
authors.initials: M
authors.lastname: Binoux
authors.forename: L
authors.initials: L
authors.lastname: Baud
mesh_terms: D000818:Animals; D001794:Blood Pressure; D001835:Body Weight; D003404:Creatinine / Q000097:blood / Q000652:urine; D004198:Disease Susceptibility; D005923:Glomerulosclerosis, Focal Segmental / Q000097:blood / Q000473:pathology* / Q000503:physiopathology; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000235:genetics / Q000502:physiology*; D007668:Kidney / Q000473:pathology; D007678:Kidney Glomerulus / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic / Q000235:genetics; D009929:Organ Size; D011507:Proteinuria / Q000652:urine; D014508:Urea / Q000097:blood
chemical_list: D018970:Insulin-Like Growth Factor Binding Protein 1; D014508:Urea; D013006:Growth Hormone; D003404:Creatinine